US Patent Issued to EPIMAB BIOTHERAPEUTICS on Feb. 3 for "Fabs-in-tandem immunoglobulin and uses thereof" (Chinese Inventor)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,185, issued on Feb. 3, was assigned to EPIMAB BIOTHERAPEUTICS INC. (Shanghai).

"Fabs-in-tandem immunoglobulin and uses thereof" was invented by Chengbin Wu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides multivalent and multispecific binding proteins that are capable of binding two or more antigens, or two or more epitopes. The present invention also provides methods of making and using such multivalent and multispecific binding proteins, including methods of using such binding proteins for prevention or treatment of various diseases, or for detecting specific antigens in vitro or in vivo."

The patent was file...